The Highlighted Issues content focuses on current, important and relevant state, national and world issues and NAMSDL’s intent to synthesize and evaluate information and present it in an informed manner.

This document describes the similarities and differences among state mandated PMP use provisions for prescribers. It reflects the increasing refinements by state officials who are trying to use the mandate to increase PMP use by health care professionals. Read more »

This document is a product of NAMSDL’s extensive review and analysis of current state laws addressing novel psychoactive substances (“NPS”) and controlled substance analogues. On a state-by-state basis, NAMSDL lays out laws pertaining to many issues, including: expeditious scheduling, definition/treatment of analogues, fentanyl-specific provisions and penalties for violations. Read more »

Including the ballot measures enacted during the November 2016 election, 29 states and the District of Columbia now allow persons with certain debilitating medical conditions to use, possess, purchase (in many cases), and cultivate (in some cases) marijuana. This summary highlights many key laws and regulations in each of the 30 jurisdictions. Read more »

This website is funded in part through a cooperative agreement from the Bureau of Justice Assistance, Office of Justice Programs, U.S. Department of Justice and a grant from the Office of National Drug Control Policy. No federal instrumentality, including the Office of Drug Control Policy, the U.S. Department of Justice or its components, operate, control, are responsible for or necessarily endorse this website (including, without limitation, its content, technical infrastructure, policies and any services or tools provided).